LENZ Therapeutics, Inc. (LENZ)
4.60
-0.08
(-1.71%)
USD |
NASDAQ |
Aug 24, 16:00
4.60
0.00 (0.00%)
After-Hours: 20:00
LENZ Therapeutics Total Liabilities (Quarterly) : 17.33M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.33M |
| March 31, 2026 | 26.04M |
| December 31, 2025 | 21.54M |
| September 30, 2025 | 16.78M |
| June 30, 2025 | 10.97M |
| March 31, 2025 | 9.242M |
| December 31, 2024 | 11.22M |
| September 30, 2024 | 8.727M |
| June 30, 2024 | 9.718M |
| March 31, 2024 | 19.16M |
| December 31, 2023 | 19.70M |
| September 30, 2023 | 62.21M |
| Date | Value |
|---|---|
| June 30, 2023 | 62.90M |
| March 31, 2023 | 33.77M |
| December 31, 2022 | 25.61M |
| September 30, 2022 | 18.39M |
| June 30, 2022 | 15.33M |
| March 31, 2022 | 17.31M |
| December 31, 2021 | 12.14M |
| September 30, 2021 | 16.02M |
| June 30, 2021 | 7.922M |
| March 31, 2021 | 6.457M |
| December 31, 2020 | 32.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 151.28M |
| Enveric Biosciences, Inc. | 0.8615M |
| Liquidia Corp. | 326.80M |
| Aquestive Therapeutics, Inc. | 188.69M |
| Impact BioMedical, Inc. | 2.733M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 236.60M |
| Shareholders Equity (Quarterly) | 219.26M |
| Debt to Equity Ratio | 0.0026 |
| Current Ratio | 13.55 |
| Net Debt Paydown Yield | 0.07% |